Voice Analysis for Monitoring Patients With Heart Failure
NCT ID: NCT06566911
Last Updated: 2024-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
70 participants
OBSERVATIONAL
2024-01-24
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remote Monitoring of Cardiac Mechanics in Heart Failure Patients
NCT06885164
Artificial Intelligence Versus Sonographer Echocardiogram Analysis and Reporting in Patients With Heart Failure
NCT07021599
Utilising AI Analysis of Sounds To prEdict heaRt failurE decOmpensation
NCT06555757
Evaluating the Reach of Clinical Decision Support for Patients With Heart Failure
NCT06847906
Electronic S3 Prediction of Hospital Readmissions for HF Exacerbation
NCT04112849
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 18 years of age.
Exclusion Criteria
* Clinically diagnosed chronic obstructive pulmonary disease (COPD)
* Treatment in ICU or IMU
* Dialysis treatment
* Previous operations on organs involved in generation of voice (vocal tract, vocal folds, etc.)
* Neurodegenerative diseases
* Pregnancy
* Inability to provide consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Mayo Clinic
OTHER
Noah Labs
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gerhard Hindricks, MD
Role: PRINCIPAL_INVESTIGATOR
German Heart Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Rochester, Minnesota, United States
Deutsches Herzzentrum der Charité
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Soumya Vungarala, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-011322
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.